Cytological Effects of Gestagen or Danazol on Dysplasia and Carcinoma in situ of the Cervix

The paper studied cytological changes in cervical dysplasia and carcinoma in situ in patients with coexisting endometriosis, using exfoliative cytology to assess hormone responsiveness after treatment with an EP combination “pseudopregnancy” therapy or danazol. It reported that dysplasia and carcinoma in situ showed morphological alterations in response to exogenous steroid hormones, with pseudopregnancy therapy showing regression in lesions up to moderate dysplasia (and some severe dysplasia), more frequent stability in most severe dysplasia and carcinoma in situ, and progression in some carcinoma in situ, whereas danazol produced fewer changes. A stated caveat is that the biological character of these borderline lesions cannot be fully inferred from morphology alone, motivating the hormone-response comparison. Relevance to endometriosis: the study specifically includes endometriosis as a comorbidity and treats it to evaluate hormone-driven changes in cervical dysplasia and carcinoma in situ, making it directly situated within endometriosis-associated hormonal response research.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works